Gilead Sciences, Inc. (GILD)
NASDAQ: GILD · Real-Time Price · USD
109.26
-0.07 (-0.06%)
Jun 4, 2025, 1:46 PM - Market open

Gilead Sciences Statistics

Total Valuation

Gilead Sciences has a market cap or net worth of $135.91 billion. The enterprise value is $152.15 billion.

Market Cap 135.91B
Enterprise Value 152.15B

Important Dates

The last earnings date was Thursday, April 24, 2025, after market close.

Earnings Date Apr 24, 2025
Ex-Dividend Date Jun 13, 2025

Share Statistics

Gilead Sciences has 1.24 billion shares outstanding. The number of shares has increased by 0.28% in one year.

Current Share Class 1.24B
Shares Outstanding 1.24B
Shares Change (YoY) +0.28%
Shares Change (QoQ) n/a
Owned by Insiders (%) 0.10%
Owned by Institutions (%) 87.51%
Float 1.24B

Valuation Ratios

The trailing PE ratio is 23.10 and the forward PE ratio is 13.43. Gilead Sciences's PEG ratio is 0.54.

PE Ratio 23.10
Forward PE 13.43
PS Ratio 4.74
Forward PS 4.63
PB Ratio 7.10
P/TBV Ratio n/a
P/FCF Ratio 13.81
P/OCF Ratio 13.11
PEG Ratio 0.54
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.09, with an EV/FCF ratio of 15.46.

EV / Earnings 25.51
EV / Sales 5.30
EV / EBITDA 11.09
EV / EBIT 13.89
EV / FCF 15.46

Financial Position

The company has a current ratio of 1.37, with a Debt / Equity ratio of 1.31.

Current Ratio 1.37
Quick Ratio 1.06
Debt / Equity 1.31
Debt / EBITDA 1.80
Debt / FCF 2.53
Interest Coverage 11.14

Financial Efficiency

Return on equity (ROE) is 32.66% and return on invested capital (ROIC) is 15.79%.

Return on Equity (ROE) 32.66%
Return on Assets (ROA) 12.14%
Return on Invested Capital (ROIC) 15.79%
Return on Capital Employed (ROCE) 24.84%
Revenue Per Employee $1.63M
Profits Per Employee $338,920
Employee Count 17,600
Asset Turnover 0.51
Inventory Turnover 3.45

Taxes

In the past 12 months, Gilead Sciences has paid $860.00 million in taxes.

Income Tax 860.00M
Effective Tax Rate 12.60%

Stock Price Statistics

The stock price has increased by +72.47% in the last 52 weeks. The beta is 0.31, so Gilead Sciences's price volatility has been lower than the market average.

Beta (5Y) 0.31
52-Week Price Change +72.47%
50-Day Moving Average 105.79
200-Day Moving Average 95.88
Relative Strength Index (RSI) 57.01
Average Volume (20 Days) 8,736,344

Short Selling Information

The latest short interest is 24.68 million, so 1.98% of the outstanding shares have been sold short.

Short Interest 24.68M
Short Previous Month 23.57M
Short % of Shares Out 1.98%
Short % of Float 1.99%
Short Ratio (days to cover) 2.68

Income Statement

In the last 12 months, Gilead Sciences had revenue of $28.74 billion and earned $5.97 billion in profits. Earnings per share was $4.73.

Revenue 28.74B
Gross Profit 22.50B
Operating Income 10.95B
Pretax Income n/a
Net Income 5.97B
EBITDA 13.72B
EBIT 10.95B
Earnings Per Share (EPS) $4.73
Full Income Statement

Balance Sheet

The company has $8.71 billion in cash and $24.95 billion in debt, giving a net cash position of -$16.24 billion or -$13.06 per share.

Cash & Cash Equivalents 8.71B
Total Debt 24.95B
Net Cash -16.24B
Net Cash Per Share -$13.06
Equity (Book Value) 19.08B
Book Value Per Share 15.39
Working Capital 4.56B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $10.37 billion and capital expenditures -$522.00 million, giving a free cash flow of $9.84 billion.

Operating Cash Flow 10.37B
Capital Expenditures -522.00M
Free Cash Flow 9.84B
FCF Per Share $7.91
Full Cash Flow Statement

Margins

Gross margin is 78.29%, with operating and profit margins of 38.11% and 20.76%.

Gross Margin 78.29%
Operating Margin 38.11%
Pretax Margin 23.75%
Profit Margin 20.76%
EBITDA Margin 47.76%
EBIT Margin 38.11%
FCF Margin 34.26%

Dividends & Yields

This stock pays an annual dividend of $3.16, which amounts to a dividend yield of 2.89%.

Dividend Per Share $3.16
Dividend Yield 2.89%
Dividend Growth (YoY) 2.63%
Years of Dividend Growth 10
Payout Ratio 66.80%
Buyback Yield -0.28%
Shareholder Yield 2.61%
Earnings Yield 4.39%
FCF Yield 7.24%
Dividend Details

Analyst Forecast

The average price target for Gilead Sciences is $110.17, which is 0.83% higher than the current price. The consensus rating is "Buy".

Price Target $110.17
Price Target Difference 0.83%
Analyst Consensus Buy
Analyst Count 25
Revenue Growth Forecast (5Y) 3.60%
EPS Growth Forecast (5Y) 93.98%
Stock Forecasts

Stock Splits

The last stock split was on January 28, 2013. It was a forward split with a ratio of 2:1.

Last Split Date Jan 28, 2013
Split Type Forward
Split Ratio 2:1

Scores

Gilead Sciences has an Altman Z-Score of 3.19 and a Piotroski F-Score of 7.

Altman Z-Score 3.19
Piotroski F-Score 7